Qianjin Pharmaceutical: Subsidiary Obtains Registration Certificate for Aluminum Magnesium Carbonate Chewable Tablets

Qianjin Pharmaceutical announced that its subsidiary, Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd., has received the "Drug Registration Certificate" for magnesium aluminate carbonate chewing tablets issued by the National Medical Products Administration. Magnesium aluminate carbonate chewable tablets are a first-line medication for the digestive system, with the effects of acid resistance, bile resistance, and mucosal protection, providing a comprehensive treatment for upper digestive tract diseases. The main ingredient, magnesium aluminate carbonate, is a crystalline powder insoluble in water, which is not absorbed by the gastrointestinal tract after oral administration, making it highly safe.